BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 8586462)

  • 21. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction.
    Chin LS; Murray SF; Zitnay KM; Rami B
    Clin Cancer Res; 1997 May; 3(5):771-6. PubMed ID: 9815748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Platelet- derived growth factor--the construction, role and it's receptors].
    Mantur M; Koper O
    Pol Merkur Lekarski; 2008 Feb; 24(140):173-6. PubMed ID: 18634279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Platelet-derived growth factor. A growth factor of great physiopathological importance].
    Westermark B
    Lakartidningen; 1995 Jun; 92(23):2397-401. PubMed ID: 7783506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-derived growth factor (PDGF) and glial tumorigenesis.
    Shih AH; Holland EC
    Cancer Lett; 2006 Feb; 232(2):139-47. PubMed ID: 16139423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
    Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
    Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin.
    Smits A; Funa K; Vassbotn FS; Beausang-Linder M; af Ekenstam F; Heldin CH; Westermark B; Nistér M
    Am J Pathol; 1992 Mar; 140(3):639-48. PubMed ID: 1372158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
    Maher DW; Strawn LM; Donoghue DJ
    Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment.
    Fomchenko EI; Holland EC
    Neurosurg Clin N Am; 2007 Jan; 18(1):39-58, viii. PubMed ID: 17244553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus.
    Uhrbom L; Hesselager G; Nistér M; Westermark B
    Cancer Res; 1998 Dec; 58(23):5275-9. PubMed ID: 9850047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H; Fredriksson L; Li X; Eriksson U
    Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microbiological approach to the treatment of brain tumors].
    Kuratsu J; Ushio Y
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):195-200. PubMed ID: 1992913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
    Bruna A; Darken RS; Rojo F; Ocaña A; Peñuelas S; Arias A; Paris R; Tortosa A; Mora J; Baselga J; Seoane J
    Cancer Cell; 2007 Feb; 11(2):147-60. PubMed ID: 17292826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
    Fry DG; Milam LD; Maher VM; McCormick JJ
    J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GM1 inhibits early signaling events mediated by PDGF receptor in cultured human glioma cells.
    Farooqui T; Kelley T; Coggeshall KM; Rampersaud AA; Yates AJ
    Anticancer Res; 1999; 19(6B):5007-13. PubMed ID: 10697503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells.
    Di Paolo S; Gesualdo L; Ranieri E; Grandaliano G; Schena FP
    Am J Pathol; 1996 Dec; 149(6):2095-106. PubMed ID: 8952542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of activated platelet-derived growth factor receptors in human meningioma.
    Shamah SM; Alberta JA; Giannobile WV; Guha A; Kwon YK; Carroll RS; Black PM; Stiles CD
    Cancer Res; 1997 Sep; 57(18):4141-7. PubMed ID: 9307305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
    Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
    Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.